AI assistant
SASOL LIMITED — Director's Dealing 2026
May 14, 2026
48815_rns_2026-05-14_a3c0348c-c7cd-4734-8d07-5800f4ede267.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Sasol Limited
(Incorporated in the Republic of South Africa)
(Registration number 1979/003231/06)
Sasol Ordinary Share codes: JSE: SOL
NYSE: SSL
Sasol Ordinary ISIN codes: ZAE000006896
US8038663006
Sasol BEE Ordinary Share code: JSE: SOLBE1
Sasol BEE Ordinary ISIN code: ZAE000151817
(Sasol, the Company, Equity issuer)
DEALINGS IN SECURITIES BY A PRESCRIBED OFFICER OF SASOL LIMITED
In compliance with paragraphs 6.77 to 6.85 of the JSE Limited Listings Requirements (Listings Requirements), the following information is disclosed relating to dealings in securities of Sasol by a prescribed officer of Sasol Limited.
The person below transacted in securities awarded and accepted in 2023 in terms of the rules of the long-term incentive (LTI) plan. This vesting is the first tranche of the 2023 LTI On Appointment award, which partially vested at the achievement of corporate performance targets, the second tranche will vest in 2028.
In line with Sasol's minimum shareholding requirement policy, the participant had the option to retain all vested shares or sell sufficient vested shares to cover the tax liability and retain the balance thereof.
All executive directors and prescribed officers of Sasol Limited must meet minimum shareholding requirements.
Details of the transactions are set out below.
| Transaction date: | 11 May 2026 |
|---|---|
| Class of securities: | Sasol ordinary shares |
| Issue price per share: | R0,00 |
| Nature of transaction: | Retention of vested shares off-market |
| Nature and extent of interest: | Direct beneficial |
| Name | Company and designation |
| --- | --- |
| S Pillay | Sasol Limited: Prescriber Officer |
1 Closing price of 8 May 2026.
| Transaction date: | 11 May 2026 |
|---|---|
| Class of securities: | Sasol ordinary shares |
| Issue price per share: | R0,00 |
| Nature of transaction: | Sale of vested shares on-market |
| Nature and extent of interest: | Direct beneficial |
| Name | Company and designation |
| --- | --- |
| S Pillay2 | Sasol Limited: Prescriber Officer |
- Average selling price per share is based on transactions effected by the Company on 11 May 2026. Proceeds are allocated to the shares sold by Directors / Prescribed Officers, as with all participants, based on the outcome of the bulk sale.
- In terms of the MSR policy, Directors and Prescribed Officers may sell vested shares to cover the taxation and transaction cost on the vested LTI award.
The highest and lowest prices, as well as the VWAP price for the day of trading are as follows:
| Date | Highest price (ZAR) | Lowest price (ZAR) | Volume Weighted Average Price (ZAR) |
|---|---|---|---|
| 11 May 2026 | 219,1500 | 211,9700 | 215,6697 |
In terms of paragraph 6.83 of the Listings Requirements, the necessary clearance to deal has been obtained for the transaction set out above.
14 May 2026
Sandton
Equity Sponsor: Merrill Lynch South Africa (Pty) Limited t/a BofA Securities